Scan to Download ios&Android APP

Trade Gemini Therapeutics, Inc. - GMTX CFD

1.54
0.65%
0.14
Low: 1.52
High: 1.55
Market Trading Hours* (UTC) Open now
Closes on Monday at 20:00

Mon - Fri: 13:30 - 20:00

Gemini Therapeutics, Inc. live chart

Still looking for a broker you can trust?
Capital.com Group
400,000+

Traders

90,000+

Active clients monthly

$65,000,000+

Monthly investing volume

$29,000,000+

Withdrawn each month

  • Summary
  • Historical Data
Trading Conditions
Long position overnight fee
-0.0225%
Short position overnight fee
-0.0219%
Overnight fee time
21:00 (UTC)
Min traded quantity
1
Currency
USD
Margin
20%
Stock exchange
United States of America
Commission on trade
0%
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 24, 2022 1.55 0.06 4.03% 1.49 1.78 1.45
Jun 23, 2022 1.51 0.08 5.59% 1.43 1.51 1.43
Jun 22, 2022 1.47 0.11 8.09% 1.36 1.47 1.35
Jun 21, 2022 1.40 -0.04 -2.78% 1.44 1.44 1.34
Jun 17, 2022 1.34 0.04 3.08% 1.30 1.40 1.30
Jun 16, 2022 1.39 0.03 2.21% 1.36 1.40 1.29
Jun 15, 2022 1.41 0.05 3.68% 1.36 1.43 1.36
Jun 14, 2022 1.42 0.06 4.41% 1.36 1.46 1.34
Jun 13, 2022 1.48 0.07 4.96% 1.41 1.53 1.34
Jun 10, 2022 1.43 0.05 3.62% 1.38 1.48 1.36
Jun 9, 2022 1.46 0.10 7.35% 1.36 1.56 1.25
Jun 8, 2022 1.43 0.02 1.42% 1.41 1.45 1.36
Jun 7, 2022 1.50 0.23 18.11% 1.27 1.56 1.27
Jun 6, 2022 1.32 0.05 3.94% 1.27 1.34 1.24
Jun 3, 2022 1.25 0.10 8.70% 1.15 1.28 1.15
Jun 2, 2022 1.17 -0.06 -4.88% 1.23 1.27 1.17
Jun 1, 2022 1.23 0.01 0.82% 1.22 1.29 1.20
May 31, 2022 1.23 0.03 2.50% 1.20 1.24 1.18
May 27, 2022 1.21 0.00 0.00% 1.21 1.22 1.18
May 26, 2022 1.15 -0.05 -4.17% 1.20 1.25 1.15

Content 2
Content 2

Key Stats

Prev. Close* 1.55
Open* 1.53
Day's Range* 1.52 - 1.52
1-Year Change* 0.66%
Volume N/A
Average Vol. (3m) 5.89554
52 wk Range N/A
Market Cap 55.3064
P/E Ratio N/A
Shares Outstanding 43.23M
Revenue N/A
EPS -1.57797
Dividend (Yield %) N/A
Beta N/A
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Gemini Therapeutics, Inc. Company profile

About Gemini Therapeutics Inc

Gemini Therapeutics, Inc., formerly FS Development Corp., is a clinical-stage precision medicine company. The Company is principally focused on developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). The Company's lead product candidate, GEM103, is a recombinant form of the human complement factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health in patients with AMD. Its Pipeline of product candidate includes (adeno-associated virus) AAV-CFH, AAV-CFI, AAV-Ab, GEM104 and GEM307. Its AAV-CFH program is complementary to GEM103 program, as AAV-CFH to construct that express GEM103 continuously at a therapeutic level. Its pipeline is designed to develop treatments for genetically subpopulations of patients suffering from dry AMD and linked diseases. The Company do not own or operate manufacturing facilities for the production of clinical or commercial quantities of its product candidates.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Gemini Therapeutics Inc revenues was not reported. Net loss increased from $812K to $71.9M. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.05 to -$1.78.

Industry: Biotechnology & Medical Research (NEC)

300 One Kendall Square, 3Rd Floor
Suite 4500
CAMBRIDGE
MASSACHUSETTS 02139
US

People Also Watch

Gold Spot

1,825.46 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0102%
Short position overnight fee -0.0092%
Overnight fee time 21:00 (UTC)
Spread 0.18

Market analysis

Gemini Therapeutics, Inc. (GMTX) Stock Moves 2.68%: What You Should Know

Gemini Therapeutics, Inc. (GMTX) stock is up 2.68% in the last day. For details on what happened in the market, see our analysis.

07:00, 27 June 2022

Learn more about

Still looking for a broker you can trust?

Join the 400.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading